Liver disease and platelet function in alcoholics
Mikhailidis et al reported that chronic alcohol ingestion exerts an inhibitory effect on platelet function even in the absence ofalcohol in the blood and that this phenomenon is reversible with abstinence. Platelet aggregation and associated thromboxane formation were inhibited on admission but returned to normal or became hyperresponsive during two to three weeks of abstinence. Their data also suggested a relation between the bleeding time and estimated alcohol intake during the week preceding detoxification. ' As alcoholic cirrhosis of the liver may cause bleeding and coagulation abnormalities we decided to see whether the inhibited platelet function of alcoholics on admission for detoxification might be related to liver disease in these patients.
Patients, methods, and results
Twenty six chronic alcoholics were studied within 24 hours of admission to our inpatient detoxification department. The subjects denied taking any drugs during the week before the study and none had salicylates in the urine on the day of admission. All gave informed consent.
All had been drinking up to the day of admission and had signs and symptoms of alcohol withdrawal, for which they were given oxazepam.2 Laboratory data showed that 16 of the 26 subjects had serum transaminase activities four times higher than normal despite normal albumin and bilirubin concentrations. These subjects gave permission for liver biopsy. In 13 cases the histological appearance of liver tissue showed fatty infiltration varying from 11% to 29%, whereas in three cases liver morphology was normal. Platelet function was studied as described. 2 Platelet values in the 13 alcoholics with fatty liver were compared with those in the three patients with normal liver morphology. A significant correlation (r=0-519; df= 15; p<0 05) was found between the degree of fatty infiltration of the liver and the bleeding time. There was no significant correlation between bleeding time and recent ethanol intake or bleeding time and the other variables of platelet function.
Prolongation of the bleeding time was found on admission in the alcoholics with fatty liver (table). The mean difference between alcoholics with and without liver disease was 137 s (95% confidence interval 72 to 202 s; t=4 30, df=24, p<0001). The capacity of blood to form thromboxane calculated as the product of platelet count and thromboxane B2 formed per 107 platelets was significantly less (t=2-36; df=24; p<0 05) in alcoholics with fatty liver than in alcoholics without signs of liver disease.
Plateletfunction values and ethanol intake in chronic alcoholics with and without liver disease on admission for detoxification and in non-alcoholic healthy male volunteers. Compared with non-alcoholic healthy volunteers *p<0.05, ***p<0o001 (Student's t test).
Comment Impaired platelet aggregation, bleeding tendency, thrombocytopenia, and defects in clotting factors are common findings in alcoholic liver disease. Liver cirrhosis is associated with arachidonate deficiency3 and decreased platelet thromboxane formation,4 but it is not known whether these occur in other types of alcoholic liver disease.
In our study alcoholics with normal liver showed diminished platelet aggregation in response to adenosine diphosphate, whereas those with fatty liver showed, in addition, prolonged bleeding time and decreased capacity of blood to form thromboxane. Bleeding time showed no significant correlation with blood thromboxane forming capacity or estimated ethanol intake during the week before admission, but a significant correlation was found between bleeding time and the degree of fatty infiltration of the liver.
These observations suggest that recent ethanol intake may influence platelet aggregation but that factors other than this and decreased platelet thromboxane formation are mainly responsible for prolongation of the bleeding time in alcoholics with fatty liver. Thromboxane release from aggregating platelets is not the main determinant of skin bleeding time. 5 In an earlier study we found that during the first two weeks of abstinence a significant shortening of the bleeding time occurs concomitantly with enhanced platelet aggregation and associated thromboxane formation.2 This seems to occur irrespective of whether alcoholics have a fatty liver or not.
Tobacco and end stage diabetic nephropathy
Tobacco has attracted attention in recent years as a possible risk factor for diabetic retinopathy and nephropathy'-3 but the subject remains controversial. We have compared tobacco usage by patients with end stage diabetic nephropathy with that in a matched diabetic control group.
Patients, methods, and results
The study group comprised 22 patients referred consecutively during the past four years to the nephrology division because of end stage diabetic nephropathy. Their glomerular filtration rate was <15 ml/min and diabetes was the only plausible cause of the renal disorder. Tobacco use was recorded retrospectively, aided by interviews of the patients or with relatives of three of the patients who died.
A control group of 22 patients with type I (insulin dependent) diabetes was obtained by selectively pairing as closely as possible each uraemic patient with one of 563 insulin treated diabetics from our special outpatient clinic. Pairing criteria were sex, age, and duration of diabetes. When a choice of controls was available we always selected the one with the longest duration of diabetes. In both groups the male to female ratio was 12:10 and the mean age 38 (SD 8) years. The mean duration of diabetes was 29 (SD 9) years in the control group and 27 (9) years in the uraemic group.
The time from recognition of diabetes to manifest albuminuria (dip stick) was recorded. The total consumption of tobacco was calculated as pack years2-that is, a person who had smoked 10 cigarettes daily for four years had accumulated two pack years. Case notes were reviewed for the onset of albuminuria. Present kidney function was evaluated in all the control patients by measuring creatinine clearance and daily quantitative urinary excretion of microalbumin. 4 There were significantly more' (case v control; x2 test, two tailed, p=0 006) tobacco users in the uraemic group (21 out of 22) than among the controls (10 out of 22) and calculations of pack years gave a higher mean value (9 25 (SD 5 73)) for the total uraemic group than for the total control group (2 53 (4-0)) (Student's t test=4-409; p<0-001). Calculated for smokers only, the respective means were Creatinine clearance and albuminuria in 22 control diabetic users and non-users oftobacco Tobacco users Non-users (n=10) (n=12)
Creatinine clearance (ml/min/I -73 m2): 
